Diseases, Conditions, Syndromes

Coronavirus deaths are rising again in the US, as feared

Deaths per day from the coronavirus in the U.S. are on the rise again, just as health experts had feared, and cases are climbing in nearly every state, despite assurances from President Donald Trump over the weekend that ...

Diseases, Conditions, Syndromes

Masks, travel restrictions, testing as virus cases surge

Governments and businesses are ramping up precautions as coronavirus case numbers rise to dire new levels in parts of the U.S. and around the world, potentially wiping out two months of progress.

Diseases, Conditions, Syndromes

Faint glimmers of hope as virus deaths slow in places

The steep rise in coronavirus deaths in New York appears to be leveling off in a possible sign that social distancing is working in the most lethal hot spot in the U.S., the governor said Monday—a trend that seems to have ...

Diseases, Conditions, Syndromes

Lockdowns multiply globally as virus strains health systems

Major streets and highways were deserted in many parts of the world Saturday as curfews and lockdowns multiplied in the face of a rapidly advancing virus that is severely straining many health systems.

Diseases, Conditions, Syndromes

Trump declares state of emergency in coronavirus-paralysed US

US President Donald Trump declared a national emergency in what critics say was a long-delayed admission of the gravity of the coronavirus crisis that has triggered the shutdown of schools, sporting events, offices and travel ...

Medications

Elan enters $1B royalty deal with Theravance

Irish drugmaker Elan Corp. PLC plans to pay $1 billion for the right to future royalties from four respiratory treatments being developed by Theravance Inc. and GlaxoSmithKline.

Medications

Lundbeck profit jumps but warns on generic pressure

Danish pharmaceutical company Lundbeck Wednesday posted a higher than expected quarterly net profit, helped by the expansion of an alliance with Japan's Otsuka and the divestment of a US portfolio of non-core products.

page 1 from 1